Andrew Saik Arvinas, Inc. (ARVN) insider trading activity

ARVN Quotes by TradingView

Andrew Saik is Chief Financial Officer of ARVINAS, INC.. Currently has a direct ownership of 110,501 shares of ARVN, which is worth approximately $997,824. The most recent transaction as insider was on Feb 13, 2025, when has been sold 49,092 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 111K
79.94% 3M change
n/a 12M change
Total Value Held $997,824

Andrew Saik Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2025
BUY
Grant, award, or other acquisition
-
49,092 Added 30.76%
110,501 Common Stock
Jun 24 2024
BUY
Grant, award, or other acquisition
-
61,409 Added 50.0%
61,409 Common Stock

Also insider at

VYNE
VYNE Therapeutics Inc. Healthcare
Chief Financial Officer
ICPT
INTERCEPT PHARMACEUTICALS, INC. Healthcare
EVP & Chief Financial Officer
MIST
Milestone Pharmaceuticals Inc. Healthcare
AS

Andrew Saik

Chief Financial Officer
Morristown, NJ

Track Institutional and Insider Activities on ARVN

Follow ARVINAS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARVN shares.

Notify only if

Insider Trading

Get notified when an Arvinas, Inc. insider buys or sells ARVN shares.

Notify only if

News

Receive news related to ARVINAS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARVN